Glaucoma is a leading cause of blindness worldwide, often progressing without noticeable symptoms until significant vision loss occurs. Traditional glaucoma surgeries can be invasive and require lengthy recovery times. However, advancements in medical technology have introduced Minimally Invasive Glaucoma Surgery (MIGS), offering patients safer and more efficient treatment options.

What is MIGS?

MIGS encompasses a range of surgical procedures designed to lower intraocular pressure (IOP) in patients with glaucoma. Unlike traditional surgeries, MIGS techniques involve smaller incisions, reduced tissue disruption, and quicker recovery times. These procedures aim to enhance the natural drainage of fluid within the eye, thereby controlling IOP and preserving vision.

Available MIGS Techniques at London Ophthalmology Centre

At London Ophthalmology Centre (LondonOC), several MIGS options are available:

• MINIject®: This procedure involves implanting a tiny strip of sponge into the eye's drainage angle, facilitating the outflow of aqueous humor and reducing IOP. The MINIject® is designed to integrate with surrounding tissue, minimising inflammation and fibrosis.
• XEN Gel Stent: A 6mm gel stent is implanted to create a new drainage pathway, effectively lowering IOP without the need for stitches.
• OMNI™ Surgical System: This device allows surgeons to perform canaloplasty and trabeculotomy through a single microincision, enhancing fluid outflow and reducing IOP.
• Hydrus Microstent: A small device is inserted into Schlemm’s canal to improve fluid drainage, often used in conjunction with cataract surgery.
• Preserflo Microshunt: A synthetic tube is implanted to create a new drainage pathway, effectively lowering IOP.

Benefits of MIGS

• Minimally Invasive: Smaller incisions lead to less tissue disruption.
• Reduced Recovery Time: Patients typically experience quicker healing compared to traditional surgeries.
• Lower Risk of Complications: The less invasive nature of MIGS procedures reduces the likelihood of postoperative issues.
• Effective IOP Control: MIGS techniques are designed to provide sustained reduction in IOP.

Why Choose London Ophthalmology Centre?

LondonOC is at the forefront of glaucoma treatment, offering state-of-the-art MIGS procedures tailored to individual patient needs. Our team of experienced surgeons, led by Mr. Vik Sharma, utilises the latest technology to ensure optimal outcomes. With a commitment to patient care and advanced treatment options, LondonOC provides a comprehensive approach to managing glaucoma.

Conclusion

MIGS represents a significant advancement in glaucoma surgery, offering patients effective and less invasive treatment options. If you are considering glaucoma surgery, consult with a specialist at LondonOC to explore the best MIGS options for your condition.